3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Brain Neoplasms
6
Neoplasm Metastasis
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Multiple Myeloma
1
Meningioma
1
Lymphoma
1
Lung Neoplasms
1
Leukemia
1
Hypogonadism
1
Head and Neck Neoplasms
1
Cognitive/Functional Effects
1
Cognitive Dysfunction
1
Breast Neoplasms, Male
1
Breast Neoplasms
1
Anatomic Stage I Breast Cancer AJCC v8
1
Interventions
pembrolizumab
64
Nivolumab
57
Ipilimumab
35
Specimen Handling
24
Magnetic Resonance Spectroscopy
21
Cyclophosphamide
16
Biopsy
13
relatlimab
11
binimetinib
11
Opdualag
11
CTLA-4 Antigen
11
trametinib
10
fludarabine
10
Radiosurgery
10
dabrafenib
8
lifileucel
7
fludarabine phosphate
7
encorafenib
7
aldesleukin
7
atezolizumab
6
Interleukin-2
6
cemiplimab
5
X-Rays
5
Paclitaxel
5
Immunoglobulin G
5
Blood Specimen Collection
5
Taxes
4
Radiotherapy
4
Pemetrexed
4
Gemcitabine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Melanoma
×
Mental Status and Dementia Tests
×
90 days
×
Clear all
No trials found.